Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
Circulating free nucleic acids; cell free DNA and circulating micro-RNA, are found in the plasma of patients with hematologic and solid malignancies at levels higher than that of healthy individuals. In patients with hematologic malignancy cell free DNA reflects the underlying tumor mutational profi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2016-06-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/927 |
id |
doaj-664a99a825ac4257ba1f5a16468737eb |
---|---|
record_format |
Article |
spelling |
doaj-664a99a825ac4257ba1f5a16468737eb2020-11-25T02:03:36ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412095-39412016-06-0113221522510.20892/j.issn.2095-3941.2016.00252016000025Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignanciesJay Hocking0Sridurga Mithraprabhu1Anna Kalff2Andrew Spencer3Myeloma Research Group, Australian Center for Blood Diseases, Monash University, Melbourne 3004, Australia;Myeloma Research Group, Australian Center for Blood Diseases, Monash University, Melbourne 3004, Australia;Malignant Haematology & Stem Cell Transplantation Service, Alfred Hospital, Melbourne 3004, AustraliaMyeloma Research Group, Australian Center for Blood Diseases, Monash University, Melbourne 3004, Australia;Circulating free nucleic acids; cell free DNA and circulating micro-RNA, are found in the plasma of patients with hematologic and solid malignancies at levels higher than that of healthy individuals. In patients with hematologic malignancy cell free DNA reflects the underlying tumor mutational profile, whilst micro-RNAs reflect genetic interference mechanisms within a tumor and potentially the surrounding microenvironment and immune effector cells. These circulating nucleic acids offer a potentially simple, non-invasive, repeatable analysis that can aid in diagnosis, prognosis and therapeutic decisions in cancer treatment.http://www.cancerbiomed.org/index.php/cocr/article/view/927Circulating nucleic acidsDNAmiRNAhematologic malignancybiopsy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jay Hocking Sridurga Mithraprabhu Anna Kalff Andrew Spencer |
spellingShingle |
Jay Hocking Sridurga Mithraprabhu Anna Kalff Andrew Spencer Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies Cancer Biology & Medicine Circulating nucleic acids DNA miRNA hematologic malignancy biopsy |
author_facet |
Jay Hocking Sridurga Mithraprabhu Anna Kalff Andrew Spencer |
author_sort |
Jay Hocking |
title |
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies |
title_short |
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies |
title_full |
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies |
title_fullStr |
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies |
title_full_unstemmed |
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies |
title_sort |
liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies |
publisher |
China Anti-Cancer Association |
series |
Cancer Biology & Medicine |
issn |
2095-3941 2095-3941 |
publishDate |
2016-06-01 |
description |
Circulating free nucleic acids; cell free DNA and circulating micro-RNA, are found in the plasma of patients with hematologic and solid malignancies at levels higher than that of healthy individuals. In patients with hematologic malignancy cell free DNA reflects the underlying tumor mutational profile, whilst micro-RNAs reflect genetic interference mechanisms within a tumor and potentially the surrounding microenvironment and immune effector cells. These circulating nucleic acids offer a potentially simple, non-invasive, repeatable analysis that can aid in diagnosis, prognosis and therapeutic decisions in cancer treatment. |
topic |
Circulating nucleic acids DNA miRNA hematologic malignancy biopsy |
url |
http://www.cancerbiomed.org/index.php/cocr/article/view/927 |
work_keys_str_mv |
AT jayhocking liquidbiopsiesforliquidtumorsemergingpotentialofcirculatingfreenucleicacidevaluationforthemanagementofhematologicmalignancies AT sridurgamithraprabhu liquidbiopsiesforliquidtumorsemergingpotentialofcirculatingfreenucleicacidevaluationforthemanagementofhematologicmalignancies AT annakalff liquidbiopsiesforliquidtumorsemergingpotentialofcirculatingfreenucleicacidevaluationforthemanagementofhematologicmalignancies AT andrewspencer liquidbiopsiesforliquidtumorsemergingpotentialofcirculatingfreenucleicacidevaluationforthemanagementofhematologicmalignancies |
_version_ |
1724947067305984000 |